Literature DB >> 11687323

A comparison of videotape and audiotape assessment of patient-centredness in family physicians' consultations.

M A Weingarten1, J Yaphe, D Blumenthal, M Oren, A Margalit.   

Abstract

The aim of this study was to compare videotape and audiotape assessments of doctors' patient-centred behaviour in primary care consultations. The patient-centredness scale of Henbest and Stewart was used to measure the quality of 856 doctor-patient interactions in 258 consultations performed by 47 primary care physicians recorded on videotape. Assessments were performed once using only the sound track and a second time using both the sound and video-tracks. On a nominal quality scale of 0-3, the average score for all consultations was 1.94 (S.D. 0.63) by audio assessment, and 1.94 (S.D. 0.59) by video assessment (P<0.8). There was excellent agreement between audio and video scores over a wide range of scores. Little information (<5%) was lost when using audiotape compared to videotape. It was technically easier to assess the video recordings. Audio recording is equivalent to video recording for the assessment of patient-centredness using the scale of Henbest and Stewart in primary care consultations.

Entities:  

Mesh:

Year:  2001        PMID: 11687323     DOI: 10.1016/s0738-3991(00)00199-3

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  2 in total

1.  Comparing audio and video data for rating communication.

Authors:  Kristine Williams; Ruth Herman; Daniel Bontempo
Journal:  West J Nurs Res       Date:  2013-04-10       Impact factor: 1.967

2.  Comparison of audio vs. audio + video for the rating of shared decision making in oncology using the observer OPTION5 instrument: an exploratory analysis.

Authors:  Michael R Gionfriddo; Megan E Branda; Cara Fernandez; Aaron Leppin; Kathleen J Yost; Brittany Kimball; Gabriela Spencer-Bonilla; Laura Larrea; Katherine E Nowakowski; Victor M Montori; Jon Tilburt
Journal:  BMC Health Serv Res       Date:  2018-07-04       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.